| Human pluripotent stem cell-derived functional sympathetic neurons express ACE2 and RAAS components: a framework for studying the effect of COVID-19 on sympathetic responsiveness HF Wu, CW Huang, KR Daga, RA Marklein, N Ivanova, N Zeltner Clinical Autonomic Research 32 (1), 59-63, 2022 | 5 | 2022 |
| Shape up before you ship out: morphology as a potential critical quality attribute for cellular therapies KR Daga, P Priyadarshani, AM Larey, K Rui, LJ Mortensen, RA Marklein Current Opinion in Biomedical Engineering 20, 100352, 2021 | 3 | 2021 |
| High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate … AM Larey, TM Spoerer, KR Daga, MG Morfin, HM Hynds, J Carpenter, ... Bioactive Materials 37, 153-171, 2024 | 1 | 2024 |
| DEVELOPMENT OF A HIGH-THROUGHPUT MICROGLIA MORPHOLOGICAL PROFILING ASSAY TO ASSESS MESENCHYMAL STROMAL CELL EXTRACELLULAR VESICLE POTENCY KR Daga, K Chen, AM Larey, CE Campagna, TS Maughon, R Marklein Cytotherapy 24 (5), S60-S61, 2022 | 1 | 2022 |
| MICROGLIA MORPHOLOGICAL RESPONSE TO MESENCHYMAL STROMAL CELL EXTRACELLULAR VESICLES DEMONSTRATES EV THERAPEUTIC POTENTIAL FOR MODULATING NEUROINFLAMMATION KR Daga, AM Larey, IF De Luna, MG Morfin, T Spoerer, S Bitarafan, ... Cytotherapy 26 (6), S73, 2024 | | 2024 |
| MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES MODULATE MICROGLIA MORPHOLOGY AND MITOCHONDRIAL CONTENT IF de Luna, KR Daga, AM Larey, R Marklein Cytotherapy 26 (6), e10-e11, 2024 | | 2024 |
| ANALYTICAL AND CELL-BASED CHARACTERIZATION OF LYOPHILIZED NEURAL STEM CELL EXTRACELLULAR VESICLES M Golan, L McCarthy, KR Daga, R Marklein, B Washington, R Ashton Cytotherapy 26 (6), e11-e12, 2024 | | 2024 |
| High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate … AM Larey, TM Spoerer, KR Daga, MG Morfin, HM Hynds, J Carpenter, ... bioRxiv, 2023 | | 2023 |
| HIGH THROUGHPUT SCREENING OF MESENCHYMAL STROMAL CELL MORPHOLOGICAL RESPONSE TO INFLAMMATORY SIGNALS FOR BIOREACTOR-BASED MANUFACTURING OF IMMUNOMODULATORY EXTRACELLULAR VESICLES AM Larey, KR Daga, CE Campagna, TS Maughon, T Spoerer, K Chen, ... CYTOTHERAPY 24 (5), S56-S57, 2022 | | 2022 |
| Mesenchymal Stem/Stromal Cells: DEVELOPMENT OF A HIGH-THROUGHPUT MICROGLIA MORPHOLOGICAL PROFILING ASSAY TO ASSESS MESENCHYMAL STROMAL CELL EXTRACELLULAR VESICLE POTENCY KR Daga, K Chen, AM Larey, CE Campagna, TS Maughon, R Marklein Cytotherapy 24 (5), S60-S61, 2022 | | 2022 |
| Mesenchymal Stem/Stromal Cells: HIGH THROUGHPUT SCREENING OF MESENCHYMAL STROMAL CELL MORPHOLOGICAL RESPONSE TO INFLAMMATORY SIGNALS FOR BIOREACTOR-BASED MANUFACTURING OF … AM Larey, KR Daga, CE Campagna, TS Maughon, T Spoerer, K Chen, ... Cytotherapy 24 (5), S56-S57, 2022 | | 2022 |
| Mesenchymal Stem/Stromal Cells: DEVELOPMENT OF A MORPHOLOGICAL PERICYTE POTENCY ASSAY FOR MSC-EVS USE IN THE CONTEXT OF NEUROINFLAMMATION CE Campagna, M Roos, TS Maughon, AM Larey, KR Daga, S Ghosh, ... Cytotherapy 24 (5), S47-S48, 2022 | | 2022 |
| Development of a morphology-based microglia potency assay to assess the therapeutic potential of MSCs for neurodegenerative diseases KR Daga, K Chen, R Marklein Cytotherapy (Oxford, England) 23 (5), S40-S41, 2021 | | 2021 |
